| 标题 |
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet (London, England) 作者:Heier JS; Khanani AM; Quezada Ruiz C; Basu K; Ferrone PJ; et al 出版日期:2022/02/19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)